Literature DB >> 18669953

Femoral impaction bone allografting with an Exeter cemented collarless, polished, tapered stem in revision hip replacement: a mean follow-up of 10.5 years.

P J Wraighte1, P W Howard.   

Abstract

Femoral impaction bone allografting has been developed as a means of restoring bone stock in revision total hip replacement. We report the results of 75 consecutive patients (75 hips) with a mean age of 68 years (35 to 87) who underwent impaction grafting using the Exeter collarless, polished, tapered femoral stem between 1992 and 1998. The mean follow-up period was 10.5 years (6.3 to 14.1). The median pre-operative bone defect score was 3 (interquartile range (IQR) 2 to 3) using the Endo-Klinik classification. The median subsidence at one year post-operatively was 2 mm (IQR 1 to 3). At the final review the median Harris hip score was 80.6 (IQR 67.6 to 88.9) and the median subsidence 2 mm (IQR 1 to 4). Incorporation of the allograft into trabecular bone and secondary remodelling were noted radiologically at the final follow-up in 87% (393 of 452 zones) and 40% (181 of 452 zones), respectively. Subsidence of the Exeter stem correlated with the pre-operative Endo-Klinik bone loss score (p = 0.037). The degree of subsidence at one year had a strong association with long-term subsidence (p < 0.001). There was a significant correlation between previous revision surgery and a poor Harris Hip score (p = 0.028), and those who had undergone previous revision surgery for infection had a higher risk of complications (p = 0.048). Survivorship at 10.5 years with any further femoral operation as the end-point was 92% (95% confidence interval 82 to 97).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669953     DOI: 10.1302/0301-620X.90B8.20390

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  15 in total

Review 1.  Revision total hip arthroplasty: the femoral side using cemented implants.

Authors:  Graeme Holt; Samantha Hook; Matthew Hubble
Journal:  Int Orthop       Date:  2010-12-17       Impact factor: 3.075

2.  Revision hip arthroplasty using impacted cancellous bone and cement: a long-term follow-up study.

Authors:  Gowthaman Arumugam; Shashi Kumar Nanjayan; Conal Quah; Philip Wraighte; Peter Howard
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-23

Review 3.  Revision arthroplasty: an update.

Authors:  D Williams; A Taylor; P McLardy-Smith
Journal:  Skeletal Radiol       Date:  2009-11       Impact factor: 2.199

4.  Femoral impaction grafting.

Authors:  John A Scanelli; Thomas E Brown
Journal:  World J Orthop       Date:  2013-01-18

Review 5.  Classifications In Brief: The Paprosky Classification of Femoral Bone Loss.

Authors:  David A Ibrahim; Navin D Fernando
Journal:  Clin Orthop Relat Res       Date:  2016-08-02       Impact factor: 4.176

6.  Reduced femoral component subsidence with improved impaction grafting at revision hip arthroplasty.

Authors:  D W Howie; S A Callary; M A McGee; N C Russell; L B Solomon
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 7.  [Allogeneic bone transplantation in hip revision surgery : Indications and potential for reconstruction].

Authors:  G A Ahmed; B Ishaque; M Rickert; C Fölsch
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

8.  The Modular Universal Tumour And Revision System (MUTARS®) in endoprosthetic revision surgery.

Authors:  Carsten Gebert; Martin Wessling; Christian Götze; Georg Gosheger; Jendrik Hardes
Journal:  Int Orthop       Date:  2010-04-09       Impact factor: 3.075

9.  Management of severe femoral bone defect in revision total hip arthroplasty--a 236 hip, 6-14-year follow-up study.

Authors:  Guo-Qiang Zhang; Yan Wang; Ji-Ying Chen; Yong-Gang Zhou; Xiu-Tang Cao; Wei Chai; Ming Ni; Xiang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

10.  What is the long-term survival of impaction allografting of the femur?

Authors:  Kevin L Garvin; Beau S Konigsberg; Natalie D Ommen; Elizabeth R Lyden
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.